Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
0.5710
-0.0130 (-2.23%)
May 29, 2026, 10:37 AM EDT - Market open

Nexalin Technology Revenue

Nexalin Technology had revenue of $14.95K in the quarter ending March 31, 2026, a decrease of -63.55%. This brings the company's revenue in the last twelve months to $275.58K, up 110.26% year-over-year. In the year 2025, Nexalin Technology had annual revenue of $301.65K with 78.78% growth.

Revenue (ttm)
$275.58K
Revenue Growth
+110.26%
P/S Ratio
43.62
Revenue / Employee
$34,448
Employees
8
Market Cap
11.75M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025301.65K132.93K78.78%
Dec 31, 2024168.72K57.97K52.35%
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020242.91K35.53K17.13%
Dec 31, 2019207.38K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IRIDEX52.58M
Trinity Biotech43.79M
Lifeward20.92M
Vivos Therapeutics19.57M
Picard Medical5.47M
Tenon Medical4.60M
Biomerica4.33M
IceCure Medical3.57M
Revenue Rankings